Pharmaceutical News

RSS

FDA approves vaccine for 2009-2010 flu season

The U.S. Food and Drug Administration today announced that it has approved a vaccine for 2009-2010 seasonal influenza in the United States.

20 Jul 2009

Genome sequencing of schistosomiasis parasites could promote drug development

Researchers have sequenced the genomes of two parasites that cause bilharzia or schistosomiasis - a disease transmitted by water-borne snails that affects more than 200 million people worldwide - "revealing potential weaknesses that could be exploited by drug developers," Nature reports (Smith, 7/15).

16 Jul 2009

Mylan receives FDA approval for generic version of thyroid deficiency treatment Cytomel

Mylan Inc. has announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Liothyronine Sodium Tablets USP, 5 mcg (base), 25 mcg (base) and 50 mcg (base).

16 Jul 2009

FDA approves Onsolis pain reliever for cancer patients

The U.S. Food and Drug Administration today approved Onsolis, medication intended for certain patients with cancer to help manage breakthrough pain – severe flares of pain that break through regular pain medication.

16 Jul 2009

Scientists report new process for producing potentially safer form of acetaminophen

Scientists in Louisiana are reporting development of a process for producing large batches of a new and potentially safer form of acetaminophen, the widely used pain-reliever now the source of growing concern over its potentially toxic effects on the liver.

15 Jul 2009

Bio manufacturers poised to follow Senate victory with house win

"A veteran California lawmaker with ties to the biotechnology industry said she thinks her proposal to protect brand-name biologic makers has enough support to carry in the House Energy and Commerce Committee," Dow Jones Newswires/Wall Street Journal reports.

15 Jul 2009

GlaxoSmithKline pledges $97 million investment in AIDS drugs for Africa, allows South African drugmaker to produce generic second-line treatment

GlaxoSmithKline (GSK) on Tuesday announced plans to invest $97 million over 10 years "to improve research, development and access to AIDS drugs in Africa," Reuters reports.

15 Jul 2009

Review of Brazil's HIV/AIDS treatment programs shows importance of generic drugs, researchers say

"Brazil has been successful in its nearly 20-year effort to treat people living with" HIV/AIDS, and generic medicines have been "a large part of the solution," according to a recent Health Affairs review, UPI reports (UPI, 7/14).

15 Jul 2009

Prevalence of artemisinin monotherapies raising risk of resistence

Almost half of all artemisinin manufacturers and malaria-endemic countries are "failing to comply" with WHO requirements to sell the treatment in combination with other drugs, which is increasing the risk that malaria parasites will develop resistance to artemsinin, Nature reports.

15 Jul 2009

Watson confirms new drug application for generic Sanctura XR

Watson Pharmaceuticals, Inc. has confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its trospium chloride extended-release 60 mg capsules prior to the expiration of a patent owned by Supernus Pharmaceuticals, Inc.

15 Jul 2009

New drug blocks common cancer pathway

Scientists have developed a new drug which can reduce the growth of tumours in mice by up to 98 per cent, according to a study published in Molecular Cancer Therapeutics ** this week.

15 Jul 2009

HELP Committee approves protection for high tech drug companies from generics

"Senators agreed Monday to give high-tech biologic drugs 12 years of market protection before generic versions can compete," according to The Associated Press.

15 Jul 2009

WHO recommends vaccine makers move forward in mass production of H1N1 vaccine

"Saying the new H1N1 [swine flu] virus is 'unstoppable', the WHO gave drug makers a full go-ahead to manufacture vaccines against the pandemic influenza strain on Monday and said healthcare workers should be the first to get one," Reuters reports (Fox, 7/14).

15 Jul 2009

Survey: Illinois seniors delay buying prescription drugs

Some seniors in Illinois are delaying buying prescription drugs because of the cost, according to the AARP. United Press International reports: "Twenty-one percent of AARP members surveyed in Illinois report not filling or delaying filling prescriptions due to cost, a survey indicated.

14 Jul 2009

FDA issues draft guidance on drug anticounterfeiting

The U.S. Food and Drug Administration has issued a draft guidance on the use of inks, pigments, flavors, and other physical-chemical identifiers (PCIDs) by manufacturers to make drug products more difficult to duplicate by counterfeiters, and to make it easier to identify the genuine version of the drug.

13 Jul 2009

Too many Australians abusing prescription drugs

The demise of yet another pop icon from the use and abuse of pharmaceutical drugs has again put the spotlight on an increasing addiction to prescription medication among the general public.

13 Jul 2009

Two drug-related legislative plans pose problems for stakeholders

"The Senate dealt a blow to the drug lobby Thursday by voting to permit people in the United States to order lower-cost drugs from Canada over the Internet," the Associated Press/Arizona Republic reports.

12 Jul 2009

WHO approves second HPV vaccine

The WHO announced Thursday it had approved a second cervical cancer vaccine, opening "U.N. agencies and partners [to] now officially buy millions of doses of the vaccine for poor countries worldwide," where an estimated 80 percent of the 280,000 annual deaths from cervical cancer occur each year, the AP/Google.com reports (7/9).

12 Jul 2009

Largest-ever study looks at safety of Non-Steroidal Anti-Inflammatory drugs (NSAIDS)

They are a group of drugs which millions of people rely on to keep pain at bay but they can have unwanted side-effects which are sometimes more serious than the original health problem. Now scientists at The University of Nottingham are taking part in the largest-ever study on the safety of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) that has ever been performed.

12 Jul 2009

FDA approves Effient (prasugrel) for heart attack in angioplasty patients

The U.S. Food and Drug Administration has approved the blood-thinning drug Effient tablets (prasugrel) to reduce the risk of blood clots from forming in patients who undergo angioplasty, a common procedure to unblock a clogged coronary artery.

12 Jul 2009